Search for: All records

Creators/Authors contains: "Czeisler, Charles A."

« Prev Next »

Total Resources

2

Resource Type
Conference Paper

0

Conference Proceeding

0

Dataset

0

Journal Article

2

Workshop Report

0

Availability
Full Text / Resource Available

2

Citation Only

0

Save Results
Excel (limit 2000)
CSV (limit 5000)
XML (limit 5000)

Have feedback or suggestions for a way to improve these results?
!

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

Robust stability of melatonin circadian phase, sleep metrics, and chronotype across months in young adults living in real‐world settings

https://doi.org/10.1111/jpi.12720

McHill, Andrew W. ; Sano, Akane ; Hilditch, Cassie J. ; Barger, Laura K. ; Czeisler, Charles A. ; Picard, Rosalind ; Klerman, Elizabeth B. ( April 2021 , Journal of Pineal Research)
null (Ed.)
Full Text Available
Exploratory assessment of pineal gland volume, composition, and urinary 6‐sulfatoxymelatonin levels on prostate cancer risk

https://doi.org/10.1002/pros.24130

Bazzi, Latifa A. ; Sigurdardottir, Lara G. ; Sigurdsson, Sigurdur ; Valdimarsdottir, Unnur ; Torfadottir, Johanna ; Aspelund, Thor ; Czeisler, Charles A. ; Lockley, Steven W. ; Jonsson, Eirikur ; Launer, Lenore ; et al ( April 2021 , The Prostate)

Abstract Introduction
Melatonin levels are partially driven by the parenchyma volume of the pineal gland. Low urinary levels of 6‐sulfatoxymelatonin have been associated with increased risk of advanced prostate cancer, but the relationship between pineal gland volume and composition and prostate cancer risk has not been examined.
Materials and Methods
We utilized data from 864 men from the AGES‐Reykjavik Study with complete pineal gland volumes and urinary 6‐sulfatoxymelatonin measurements. Pineal parenchyma, calcification, and cyst volumes were calculated from brain magnetic resonance imaging. Levels of 6‐sulfatoxymelatonin were assayed from prediagnostic urine samples. We calculated Pearson correlation coefficients between parenchyma volume and urinary 6‐sulfatoxymelatonin levels. We used Cox proportional hazards regression to calculate multivariable hazard ratios (HRs) and 95% confidence intervals (95% CIs) comparing prostate cancer risk across parenchyma volume tertiles and across categories factoring in parenchyma volume, gland composition, and urinary 6‐sulfatoxymelatonin level.
Results
Parenchyma volume was moderately correlated with urinary 6‐sulfatoxymelatonin level (r = .24;p < .01). There was no statistically significant association between parenchyma volume tertile and prostate cancer risk. Men with high parenchyma volume, pineal cysts and calcifications, and low urinary 6‐sulfatoxymelatonin levels had almost twice the risk of total prostate cancer as men with low parenchyma volume, no pineal calcifications or cysts, and low urinary 6‐sulfatoxymelatonin levels (HR: 1.98; 95% CI: 1.02, 3.84;p: .04).
Conclusions
Although parenchyma volume is not associated with prostate cancer risk, pineal gland composition and other circadian dynamics may influence risk for prostate cancer. Additional studies are needed to examine the interplay of pineal gland volume, composition, and melatonin levels on prostate cancer risk.

more » « less